( January 30, 2025, 2:26 PM EST) -- WASHINGTON, D.C. — In a pair of Jan. 29 opinions, a panel in the Federal Circuit U.S. Court of Appeals affirmed a West Virginia federal judge’s decision to grant preliminary injunctions against two biosimilar manufacturers that barred them from marketing products that were biosimilars to an eye medication patented by Regeneron Pharmaceuticals Inc.; the panel rejected jurisdictional and validity arguments raised by the companies....